Current Issue
Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3
Robert Dream, Managing Director, HDR Company LLC
Advances and Challenges in Vaccine Development and Manufacture
Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...
Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...
Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...
Lifetime Study for JSR Amsphere A3 – Protein A Resin
JSR Life Sciences
Featured Articles
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Characterization and Engineering Performance of the Allegro™ STR 500 Single-Use Stirred Tank Bioreactor
Coupling single-pass TFF before loading onto a chromatography sorbent
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
View All Featured ArticlesHeadline News
FDA approves Johnson & Johnson’s IMAAVY as the first treatment ever cleared for warm autoimmune hemolytic anemia, marking a major step forward for patients
Merck and Moderna’s Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA meets endpoints for recurrence-free survival and distant metastasis-free survival in patients with completely resected stage IIB-IV melanoma
Hibsago receives approval in Japan as the first and only functional cure for chronic hepatitis B
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Machine Learning in Bioprocess Development: Where We Are and Where We Could Go
Presented by Rui Portela, Senior Data Scientist, GlaxoSmithKline Vaccines and Klaus Mauch, CEO at Insilico Biotechnology AG
06th May 2020
Interface Machine Learning Process Analytical Technology and Process Science For Next Level Process Development.
Presented by Oliver Steinhof, Senior Scientist Process Analytical Technologies (PAT) at Biogen and Martin Gadsby, Owner, Optimal Industrial Technologies Ltd
05th April 2022
Manufacturing strategies for Biosimilars: A case of continuous capture
Presented by Solomon Alva, Antibody Purification Group Lead, Senior Scientific Manager, Biocon Research Limited
15th June 2018
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Column Packing Protocol for Amsphere A3
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Best Practices for Achieving Virus Safety
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
